MedElevator
Войти в исследования Journal of applied research in intellectual disabilities : JARID · 2026
Changing Patterns of Psychotropics Use Among Older Adults With Intellectual Disability Over a Decade, With a Focus on Designated Mental Health Conditions.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gorman Ashleigh, Odalović Marina, Paul Aviejay, McCallion Philip, Burke Éilish, MacLachlan Malcolm, McCarron Mary, Henman Martin C, Moran Maeve, O'Connell Juliette, Shankar Rohit, Ryan Caitríona M, Ryan Cristín, O'Dwyer Máire
Аннотация
BACKGROUND: Psychotropics (sometimes off-label), mental health diagnoses and behaviours of concern are common in older adults with intellectual disability. Guidelines recommend non-pharmacological interventions and regular medication review. This study examined changes in psychotropics among older adults (≥ 40) with intellectual disability.
METHODS: Longitudinal data were obtained from the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing (IDS-TILDA) at two timepoints [Wave 1(2009/10); Wave 4(2019/20)]. Post hoc analysis, Chi-squared tests and univariate binary logistic regression were conducted.
RESULTS: Overall, psychotropics decreased (59.2% to 56.5%). Significant decreases in antipsychotics (43.1%-40.1%) and sedatives/hypnotics (13.6%-8.1%) and significant increase in antidepressants (26.2%-31.8%) were found. Nearly half of antidepressant users reported depression at Wave 1, compared with under 30% at Wave 4. Antipsychotics and antidepressants were common (75% and 60%, respectively) among those with behaviours of concern, after excluding clinical indications.
CONCLUSION: Psychotropic prescribing remained consistent, though class-specific patterns shifted, with some decreases or increases observed.
METHODS: Longitudinal data were obtained from the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing (IDS-TILDA) at two timepoints [Wave 1(2009/10); Wave 4(2019/20)]. Post hoc analysis, Chi-squared tests and univariate binary logistic regression were conducted.
RESULTS: Overall, psychotropics decreased (59.2% to 56.5%). Significant decreases in antipsychotics (43.1%-40.1%) and sedatives/hypnotics (13.6%-8.1%) and significant increase in antidepressants (26.2%-31.8%) were found. Nearly half of antidepressant users reported depression at Wave 1, compared with under 30% at Wave 4. Antipsychotics and antidepressants were common (75% and 60%, respectively) among those with behaviours of concern, after excluding clinical indications.
CONCLUSION: Psychotropic prescribing remained consistent, though class-specific patterns shifted, with some decreases or increases observed.